Cover Image

β-blockades and the risk of atrial fibrillation in patients with cardiovascular diseases

Backgroundβ-blockers have been widely used in patients with extensive cardiovascular disease (CVD) and have provided benefits. However, they are more likely to cause symptomatic bradycardia, hypotension, or glucose metabolism disorders, which may lead to an increased risk of atrial fibrillation (AF)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xun-Hu Gu (Author), Weichao Li (Author), Heng Li (Author), Xun Guo (Author), Jiang He (Author), Yuyan Liu (Author), Jianping Gong (Author), Yizhou Huang (Author), Bin Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

USP38 exacerbates atrial inflammation, fibrosis, and susceptibility to atrial fibrillation after myocardial infarction in mice
by: Yang Gong, et al.
Published: (2023)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015)

Impact of Prolonged Cycle Length Resulting From Conversion of Atrial Fibrillation to Atrial Tachycardia on Ablation Outcome in Persistent Atrial Fibrillation Ablation
by: Jialing He, et al.
Published: (2024)

Hydrogen Sulfide Ameliorates Angiotensin II-Induced Atrial Fibrosis Progression to Atrial Fibrillation Through Inhibition of the Warburg Effect and Endoplasmic Reticulum Stress
by: Heng-Jing Hu, et al.
Published: (2021)

Atrial Fibrillation Mechanisms and Treatment
Published: (2013)

HYPERTHYROIDISM AND ATRIAL FIBRILLATION
by: I. M. Marusenko, et al.
Published: (2017)

Screening for atrial fibrillation
by: Zhenisgul Tlegenova, et al.
Published: (2018)

The Utility of Speckle Tracking Echocardiographic Parameters in Predicting Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Non-Valvular Atrial Fibrillation
by: Zeng D, et al.
Published: (2024)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022)

Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
by: Shin-Yi Lin, et al.
Published: (2021)

Atrial Fibrillation Basic Research and Clinical Applications
Published: (2012)

The Therapeutic Potential of MicroRNAs in Atrial Fibrillation
by: Xiaona Xu, et al.
Published: (2020)

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
by: Francisco Marin, et al.
Published: (2023)

Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
by: Xinyu Yang, et al.
Published: (2018)

Clinical analysis of atrial fibrillation in pregnant women
by: H. F. Zhang, et al.
Published: (2020)

Atrial Fibrillation Diagnosis and Management in the 21st Century
Published: (2022)

Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation
by: Yang-Qi Pan, et al.
Published: (2024)

Stroke, Dementia and Atrial Fibrillation
Published: (2020)

Epidemiology and Treatment of Atrial Fibrillation
Published: (2020)

New Perspective in Atrial Fibrillation
Published: (2021)

Atrial Fibrillation Secondary to Dehydration
by: Kriti Bhatia
Published: (2014)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021)

Iron deficiency and atrial fibrillation
by: Metin Okşul, et al.
Published: (2018)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta-Analysis of Prospective Studies
by: Jialing He, et al.
Published: (2024)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
by: Yihong Sun, et al.
Published: (2019)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
by: Haotian Ma, et al.
Published: (2021)

Catecholamine Vasopressors and the Risk of Atrial Fibrillation After Noncardiac Surgery: A Prospective Observational Study
by: Li W, et al.
Published: (2024)

Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial
by: Amalia Baroutidou MD, et al.
Published: (2022)

Identification of potential crucial genes in atrial fibrillation: a bioinformatic analysis
by: Junguo Zhang, et al.
Published: (2020)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
by: Sijie Chang, et al.
Published: (2023)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
by: Phil Mendys, et al.
Published: (2021)

Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels
by: Jinshan He, et al.
Published: (2022)

Costs and Cardiovascular Benefits of a Fourth-Generation Synchronous Telehealth Program on Mortality and Cardiovascular Outcomes for Patients With Atrial Fibrillation: Retrospective Cohort Study
by: Hao-Yun Chang, et al.
Published: (2024)

An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation
by: Mariana Floria, et al.
Published: (2024)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
by: Ya Suo, et al.
Published: (2019)

The validity and reliability of Indonesian version of atrial fibrillation effect on quality of life (AFEQT) questionnaire for atrial fibrillation patients
by: Putri Zulmiyusrini, et al.
Published: (2023)